This 45 minute webinar explores returning to in-person SBER in a time of uncertainty.
Join Dr. Myra Luna-Lucero as she explores the critical steps necessary for returning to in-person research. In discussing this complex transition Dr Luna-Lucero will cover a range of topics including the support structure, guidance and adaptation of documentation that will be required of IRB personnel and researchers.
This webinar one-hour webinar will cover how to:
Establish a compliance and safety support structure for researchers and IRBs
Create research ramp-up (and ramp-down) phases
Plan for current and future in-person research and data collection
Develop research safety and hygiene policies and procedures
Set clear expectations, remain transparent, and create teachable moments through support and understanding
Dr. Myra Luna-Lucero, Ed.D., is the research compliance director at Teachers College, Columbia University.
During this 15 minute webinar on Scenario Planning, you will learn how to apply this tool to your future plans. Scenario Planning was developed by Shell Oil in the 1970’s and has been shown to be effective when the future is unlikely to be similar to the past. We focus on how to use Scenario Planning with your IRB team. You will also see how this can be useful in other contexts.
IRBs are prone to mission creep and mis-interpretation of the federal regulations. This webinar focuses on IRB practices in reviewing social science types of research projects. This webinar will guide participants through the application of the regulatory definitions of research and human subjects and minimal risk, the exemption categories, as well as discuss issues of scientific design in relation to risks and benefits. The webinar will also discuss informed consent and the conditions for waiver of informed consent. Our goal is to establish clear boundaries for IRB authority and explore reasons why IRBs often exceed them.
Apply the regulatory language that determines if IRB review is required, and if so, at what level.
Apply an understanding of the role scientific design plays in review of minimal risk research.